Table 4. The correlation between miRNA expression and clinical parameters in GC patients (n = 74).

miRNA level	Cases (n)	Gender			Age (years)			Chemotherapy response
		Male	Female	P-value	<60	≥60	P-value	Sensitive	Resistant	P-value
miR-9-3p	74	52	22	0.2413	23	51	0.5856	34	40	<0.0001****
low	37	24	13			9		28			24	13
high	37	28	9		14	23		10	27
miR-9-5p	74	52	22	0.8557	23	51	0.9262	34	40	<0.0001****
low	37	28	9			11		26			26	11
high	37	24	13		12	25		8	29
miR-146a-5p	74	52	22	0.7469	23	51	0.6510	34	40	<0.0001****
low	37	26	11			12		25			12	25
high	37	26	11		11	26		22	15
miR-370-3p	74	52	22	0.1757	23	51	0.8257	34	40	0.0611
low	37	23	14			13		24			20	17
high	37	29	8		10	27		14	23
miR-433-3p	74	52	22	0.1848	23	51	0.3408	34	40	<0.0001****
low	37	24	13			9		28			24	13
high	37	28	9		14	23		10	27
miR-519a-5p	74	52	22	0.4414	23	51	0.1552	34	40	0.4028
low	37	24	13			9		28			18	19
high	37	28	9		14	23		16	21
miR-522-5p	74	52	22	0.4414	23	51	0.1552	34	40	0.4028
low	37	24	13			9		28			18	19
high	37	28	9		14	23		16	21